Skip to content

Diamedix 720-520

by Diamedix Corp.

Diamedix 720-520 is a Class II device made by Diamedix Corp., cleared under FDA 510(k) K012053 on 20 Aug 2001 and listed in FDA GUDID since 20 Sep 2016 (UDI-DI 00817273020297), active as of 22 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

510(k) K012053

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00817273020297 UDI-DI Date20 Sep 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK012053 Date20 Aug 2001DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K012053 decided 20 Aug 2001 Active
  • FDA GUDID UDI-DI 00817273020297 listed 20 Sep 2016 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K012053
  2. Listed FDA GUDID 00817273020297

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Diamedix
Generic name
Measles virus immunoglobulin G (IgG) antibody IVD, kit, complement fixation test (CFT)
Model / reference
720-520
Description
"720-520 Measles IgG Test Kit"
Primary DI / UDI-DI
00817273020297
510(k) Number
FDA product code
MID
GMDN term
Measles virus immunoglobulin G (IgG) antibody IVD, kit, complement fixation test (CFT)
Device class
Class II
Regulation number
866.5660
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code MID (System, Test, Anticardiolipin Immunological).

Other devices from Diamedix Corp.

See all devices from Diamedix Corp. →

Properties

  • Convenience kit
  • Lot / batch number
Other properties (13, all answered No)